WCN26-3233 BASELINE AND EARLY-CHANGE RETICULOCYTE HEMOGLOBIN EQUIVALENT (RET-HE) PREDICTS RESPONSE TO INTRAVENOUS IRON IN MAINTENANCE HEMODIALYSIS PATIENTS

Read full text Summarise with VIRAT
Authors: Manish Malik, Umang Kasturi, Jyoti Kotwal, Vinant Bhargava, Akhilesh Kumar Jaiswal, Tarun Kumar, Rajdeb Saha, Vaibhav Tiwari, Anurag Gupta, Ashwani Gupta, Anil Kumar Bhalla, D.S. Rana
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Effective management of anemia in patients on maintenance hemodialysis (MHD) is crucial, yet traditional iron status markers like ferritin and transferrin saturation (TSAT) are often confounded by inflammation. Reticulocyte hemoglobin equivalent (RET-He), a direct measure of iron incorporation into erythroid precursors, is a promising real-time indicator of functional iron availability. This study aimed to evaluate the utility of baseline and early post-treatment RET-He in predicting hemoglobin response to intravenous (IV) iron therapy in an Indian MHD population.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Iron Metabolism and Disorders Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105209–105209
Publication date
25 March 2026
Language
EN